Here are relevant reports on : companion-diagnostics-market
-
Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024
The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Early Toxicity Testing Market by Technique (In-vivo, In-vitro, & In-Silico), End-user (Pharmaceutical, Diagnostics, Food, Chemicals, Cosmetics, & Others), Trend & Global Forecast to 2019
Toxicity is an extent to which a particular substance can damage the living organism; it is important parameter to be evaluated during all stages of drug development. Toxicity testing is conducted to determine the degree to which a substance can damage a living or non-living organism. Owing to the higher rejection rate of drug in the recent years citing high toxicity level, the companies have started using toxicity testing in drug discovery
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031
The Middle East & Africa in vitro diagnostics (IVD) market, valued at USD 3.33 billion in 2025, stood at USD 3.49 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 4.42 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Sepsis Diagnostics Market by Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Global Forecast to 2029
The global sepsis Diagnostics market, valued at US$566 million in 2022, stood at US$634 million in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$890 million by the end of the period. The market growth is driven ongoing transformation of the US & European health systems towards value-based care, recent advances in biomarker-based diagnostic methods, and technological innovations in molecular diagnostics.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Construction & Mining Fleet Management Market by Solution (Operations Management, Battery Maintenance & Diagnostics, Performance Management, Fleet Analytics & Reporting), Fleet Type (Passenger Cabs, Commercial, Public Transport) - Global Forecast to 2030
The construction & mining fleet management market is projected to reach USD 7.28 billion by 2030, growing from USD 4.04 billion in 2025 at a CAGR of 12.5% during the forecast period. The key players include Caterpillar (US), Komatsu (Japan), Volvo (Sweden), Samsara (US), Wenco (Canada), Hexagon (Sweden), Sandvik (Sweden), RPMGlobal (Australia), Verizon Connect (US), Teletrac Navman (US), JCB (UK), Liebherr (Switzerland), CNH Industrial America (US), Geotab (Canada), and Epiroc (Sweden).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
